Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research SessionMarlborough, Massachusetts--(Newsfile ...

Lisa Riley has described herself as a 'self-confessed control freak' as she revealed the reason why she has chosen not to ...

The energy storage industry has continued to progress over the course of 2024 and into 2025, buoyed in significant part by the federal income ...

From cognitive enhancement to mood support and increased energy levels, methylene blue has gained popularity for its ...

Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures –– UDENYCA® net revenue increased 62% ...

Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...

Final analysis from IGNITE Phase 2 clinical trial planned for second quarter of 2025: The Company plans to report the final ...

Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 - - On track to report ...

Chronic Kidney Disease is a silent killer that progresses gradually, often going unnoticed until the late stages. While ...

There is growing panic over the outbreak of the disease known as diphtheria in different parts of Nigeria. Diphtheria, also recognised as one of the six killer diseases of children, was thought to ...

In developing hearts, cells shuffle around, bumping into each other to find their place, and the stakes are high: pairing ...